$0.171000
0.0021.18%
Last update: 9:06 AM
15 minutes delayed
Qualigen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Qualigen Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-08 | $-0.47 | $-0.52 | 9.62 % |
Sep 2023 | 2023-11-14 | $-0.64 | $-0.92 | 30.4 % |
Jun 2023 | 2023-08-15 | $-0.69 | $-0.52 | -32.7 % |
Sep 2022 | 2022-11-15 | $-1.00 | $-1.30 | 23.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-14 | $0 | $500.00K | -100.0 % |
Jun 2023 | 2023-08-15 | $1.63M | $1.60M | 1.69 % |
Mar 2023 | 2023-05-16 | $1.61M | $2.00M | -19.6 % |
Sep 2022 | 2022-11-15 | $1.44M | $1.62M | -11.1 % |
Qualigen Therapeutics (QLGN) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.20, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.